Deciding on benefits of emerging technologies under international and European law - In The case of CRISPR
We are excited to announce the start of our new project here at the Chair of Food Law, Campus Kulmbach, University Bayreuth, in cooperation with the Federal Office of Consumer Protection and Food Safety (BVL), the Hasso Plattner Institute in Potsdam and Stanford University.
The CRISPR technology is new and risks remain unclear for certain applications. At the same time the potential benefits are enormous. This research project is innovative in that it is the first to propose a comprehensive insight into the concept of 'benefits' that lies beyond the traditional risk-based regulatory mechanisms. The project seeks to generate an understanding of the benefits of new technologies in biosciences under EU law and provide arguments that could be used in CRISPR regulation